India Pharmaceutical Contract Manufacturing And Research Services Market
India Pharmaceutical Contract Manufacturing And Research Services Market, 2018-2030 (US$M)
Global Market
Related Markets
India pharmaceutical contract manufacturing and research services market highlights
- The India pharmaceutical contract manufacturing and research services market generated a revenue of USD 23,224.7 million in 2023 and is expected to reach USD 39,897.3 million by 2030.
- The India market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, manufacturing was the largest revenue generating service in 2023.
- Research is the most lucrative service segment registering the fastest growth during the forecast period.
Pharmaceutical contract manufacturing and research services market data book summary
| Market revenue in 2023 | USD 23,224.7 million |
| Market revenue in 2030 | USD 39,897.3 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | Manufacturing |
| Fastest growing segment | Research |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Manufacturing, Research |
| Key market players worldwide | Catalent Inc, Pharmaceutical Product Development, AbbVie Inc, Baxter International Inc, Grifols SA Ordinary Shares - Class A, Dalton Pharma Services, Boehringer Ingelheim, Lonza Group Ltd |
Other key industry trends
- In terms of revenue, India accounted for 9.5% of the global pharmaceutical contract manufacturing and research services market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China pharmaceutical contract manufacturing and research services market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 34,847.7 million by 2030.
India pharmaceutical contract manufacturing and research services market is rapidly growing as a result of presence of low-cost manufacturing facilities and WHO-GMP-approved production premises in the country as well as expiring drug patents.
Manufacturing cost in India is nearly 30% to 40% lower than that in the U.S. or Europe. Low manufacturing costs can be attributed to lower capital & equipment expenses, which leads to lower costs on interest.
No credit card required*
Publish Date: Jul 03, 2024
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Pharmaceutical Contract Manufacturing Market
Pharmaceutical Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Baxter International Inc | View profile | 60,000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | www.baxter.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Catalent Inc | View profile | 17,219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | www.catalent.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23,737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | www.grifols.com |
| Pharmaceutical Product Development | View profile | 10001+ | Wilmington, North Carolina, United States, North America | ppd.com |
| Dalton Pharma Services | View profile | 51-100 | Toronto, Ontario, Canada, North America | www.dalton.com/ |
India pharmaceutical contract manufacturing market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical Contract Manufacturing And Research Services Market will help companies and investors design strategic landscapes.
Manufacturing was the largest segment with a revenue share of 66.17% in 2023.
Horizon Databook has segmented the India pharmaceutical contract manufacturing and research services market based on manufacturing, research covering the revenue growth of each sub-segment from 2018 to 2030.
India pharmaceutical contract manufacturing and research services market is rapidly growing as a result of presence of low-cost manufacturing facilities and WHO-GMP-approved production premises in the country as well as expiring drug patents.
Manufacturing cost in India is nearly 30% to 40% lower than that in the U.S. or Europe. Low manufacturing costs can be attributed to lower capital & equipment expenses, which leads to lower costs on interest.
- India Pharmaceutical Contract Manufacturing And Research Services Market Service Outlook (Revenue, USD Million , 2018-2030)
- Manufacturing
- Research
Reasons to subscribe to pharmaceutical contract manufacturing market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of pharmaceutical contract manufacturing market databook
- Our clientele includes a mix of pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India pharmaceutical contract manufacturing market, including forecasts for subscribers. This country databook contains high-level insights into India pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
India Pharmaceutical Contract Manufacturing And Research Services Market, 2018-2030 (US$M)
India pharmaceutical contract manufacturing market statistics, by service, 2018-2030 (US$M)
